, supported that finding. It showed that Wegovy could profit men and women with coronary heart failure and obesity, independently of weight loss. Krumholz explained this supports the concept Wegovy might be applied to be a heart failure treatment along with an obesity medication. Gitanjali Srivastava, MD, an adult and https://paulv753qyh1.dekaronwiki.com/user